Skip to main content

PENICILLAMINE

Tracking # 20-830343

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

PENICILLAMINE HAS FDA APPROVAL AS A TREATMENT FOR WILSON DISEASE AND CYSTINURIA. IT IS USED AS AN OFF-LABEL TREATMENT OPTION FOR LEAD POISONING IN CHILDREN. THIS ACTIVITY PRESENTS THE INDICATIONS, CONTRAINDICATIONS, AND SIDE EFFECTS OF PENICILLAMINE AND HIGHLIGHTS THE INTERPROFESSIONAL TEAM'S ROLE IN THE MANAGEMENT OF PATIENTS WITH WILSON DISEASE AND LEAD POISONING.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Osteopathic Medicine

Osteopathic Physician

1h General